Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.7702
-0.0025 (-0.32%)
Jun 10, 2026, 4:00 PM EDT - Market closed
Longeveron Employees
Longeveron had 38 employees as of December 31, 2025. The number of employees increased by 12 or 46.15% compared to the previous year.
Employees
38
Change (1Y)
12
Growth (1Y)
46.15%
Revenue / Employee
$32,000
Profits / Employee
-$590,237
Market Cap
23.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 38 | 12 | 46.15% | 38 | 0 |
| Dec 31, 2024 | 26 | 2 | 8.33% | 26 | 0 |
| Dec 31, 2023 | 24 | 3 | 14.29% | 23 | 1 |
| Dec 31, 2022 | 21 | 1 | 5.00% | 19 | 2 |
| Dec 31, 2021 | 20 | 8 | 66.67% | 18 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 115 |
| Palatin Technologies | 29 |
| Quantum BioPharma | 17 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Tvardi Therapeutics | 12 |
| Neuphoria Therapeutics | 8 |
LGVN News
- 1 day ago - Longeveron granted SME status by European Medicines Agency - TheFly
- 1 day ago - Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA) - GlobeNewsWire
- 6 days ago - Longeveron to Present at BIO International Convention 2026 - GlobeNewsWire
- 21 days ago - Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities - GlobeNewsWire
- 21 days ago - Longeveron Proxy statement: Proxy filing - Filings
- 21 days ago - Longeveron Proxy statement: Proxy filing - Filings
- 4 weeks ago - Longeveron reports Q1 EPS (19c) vs. (34c) last year - TheFly
- 4 weeks ago - Longeveron Earnings Call Transcript: Q1 2026 - Transcripts